AI Powered Diagnostics
Evora Technology
AI-Powered Diagnostics Designed for Faster Answers
Evora Diagnostics is developing advanced diagnostic technologies that combine artificial intelligence, machine learning, and innovative biosensing platforms to deliver rapid, accurate, and accessible testing.
Designed for use across hospitals, clinics, laboratories, and pharmacies, our platform aims to help patients receive answers sooner and healthcare providers make informed decisions faster.
OVERVIEW
A Platform Built for the Future
While many diagnostic technologies are designed for a single disease, Evora is developing a flexible platform capable of supporting multiple disease categories through a scalable and adaptable architecture.
As healthcare continues to evolve toward personalized medicine, telehealth integration, home-based care, and community-based healthcare delivery, rapid and reliable diagnostics will become increasingly important. Evora is building technologies designed to support that future.
How It Works
From Sample to Results
Evora’s diagnostic platform uses machine learning to interpret multiplexed immune-response signals from patient samples. By analyzing antibody binding patterns across a panel of synthetic peptide biomarkers, the platform generates diagnostic classifications designed to support rapid, single-tier testing for Lyme disease and other conditions.
Platform Highlights
Single drop of blood
AI-powered interpretation
Portable testing platform
Results in under 20 minutes
Designed for point-of-care use
The Evora Platform
Combining Advanced Biosensing and Artificial Intelligence
The platform uses a paper-based multiplexed vertical flow assay to detect patient antibody responses associated with disease.
A small sample is added to the assay, where antibody binding is captured as a measurable signal. A portable handheld reader then processes the multiplexed signal pattern and applies machine learning algorithms to generate an objective diagnostic result.
By combining innovative biosensing technology with artificial intelligence-driven analysis, Evora is developing a faster and more accessible alternative to traditional diagnostic workflows.
Accuracy
Designed for Reliable Results
In blinded validation studies using multiple samples from Lyme Disease biobanks, Evora’s platform demonstrated greater than 90% sensitivity and approximately 100% specificity.
Additional blinded evaluations using CDC Lyme disease repository samples demonstrated strong agreement with standard two-tier testing while differentiating Lyme disease from look-alike conditions without observed cross-reactivity in those cohorts.
Evora continues to advance clinical validation efforts as part of ongoing development and regulatory planning.
Speed
Results in Under 20 Minutes
Traditional laboratory-based testing can require multiple steps, centralized processing, and lengthy turnaround times.
Evora’s platform is designed to generate results in less than 20 minutes, providing a faster alternative to conventional testing workflows and helping reduce delays between testing and actionable information.
Testing Environments
Testing Where It Matters Most
Because the platform is paper-based, portable, and compatible with handheld readout technology, it is designed for deployment across a wide range of healthcare settings.
Potential Applications:
- Pharmacies
- Clinics
- Hospitals
- Laboratories
By expanding access to testing beyond centralized laboratories, Evora aims to improve convenience, accessibility, and timely decision-making.
Scientific Foundation
Built on Years of Research and Validation
Evora’s technology originates from groundbreaking research and innovation at UCLA through collaborations among the Electrical & Computer Engineering Department, the Bioengineering Department, and the California NanoSystems Institute (CNSI).
The platform is supported by:
- 10+ peer-reviewed scientific publications
- Multiple patents and patent applications
- Clinical validation studies
- Years of interdisciplinary research and development
Advancing the Future of Diagnostics
Through artificial intelligence, machine learning, and innovative biosensing technologies, Evora Diagnostics is working to make diagnostic testing faster, more accessible, and more actionable.